Print this page



Acronym
Trial Name
Appropriate Blood pressure Control in Diabetes – Part 2 with Valsartan
Aspirin and simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes
Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension
Action to Control Cardiovascular Risk in Diabetes
Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events
Atrial Fibrillation and Congestive Heart Failure
Albumin in Acute Stroke
Australian National Blood Pressure study 2
Angiotensin II antagonist In Paroxysmal Atrial Fibrillation
Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 6 – HDL and LDL Treatment Strategies
Aspirin non-responsiveness and Clopidogrel Endpoint Trial
Aortic Stenosis progression Observation: Measuring Effects of Rosuvastatin
Anticoagulation and Risk factors In Atrial fibrillation
Morbidity-mortality Evaluation of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction
Carotid Atorvastatin Study in Hyperlipidemic post-Menopausal women
Compliance and quality of life study comparing once-daily controlled-release carvedilol and twice-daily immediate-release carvedilol in patients with heart failure
Second Chinese Cardiac Study
Comparison of the Effects Noted in the ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acute coronary Syndrome
Controlling Hypertension and Hypotension Immediately Post-Stroke
Clopidogrel to Improve Primary percutaneous coronary intervention in Acute Myocardial Infarction
Combination therapy of hypertension to Prevent cardiovascular Events
Continue Or Stop post-Stroke Antihypertensives Collaborative Study
Clinical Outcomes Utilizing Revascularization and Aggressive Guideline-driven drug Evaluation
Coronary Prevention and Hypertension Research Project
Cardiovascular risk Reduction by Early Anemia Treatment with Epoetin beta
Chronic Renal Insufficiency Cohort
Diabetic Atherosclerosis Prevention by Cilostazol
Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation Acute Coronary Syndrome
Evaluation of Nifedipine and Cerivastatin On Recovery of Endothelial function II
Ezetimibe and Simvastatin in Hypercholesterolemia Enhances atherosclerosis regression
Efficacy of Nitric Oxide in Stroke
European Risk and Incidence, a Coordinated Analysis
Early Self Controlled Anticoagulation Trial II
Extended Clinical prophylaxis in Acutely Ill Medical patients
Fluvastatin in the therapy of Acute Coronary Syndrome
Finnish Cardiovascular Study
Fosinopril in Dialysis
Follow-Up Serial Infusions Of Nesiritide II
Glucose-Insulin-Potassium Study – 2
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocradico – Atrial Fibrillation
Hypertension in Diabetes Study
Heart failure revascularisation trial
Hyperglycemia and its Effect after Acute Myocardial infarction on cardiovascular outcomes in patients with Type 2 Diabetes mellitus
High-risk and Population strategy for Occupational Health Promotion
High-density lipoprotein Intervention Trial
Hypertension Objective treatment based on Measurement by Electrical Devices of BP
Heart Outcomes Prevention Evaluation – 2
Investigation on Colchicine for Acute Pericarditis
Isfahan Healthy Heart Programme
Irbesartan in the Management of Proteinuric patients at high risk for Vascular Events
Improved Reduction of Outcomes: Vytorin Efficacy International Trial
Incipient to Overt: Angiotensin II receptor blocker, Telmisartan, Investigation On type 2 diabetic Nephropathy
Japanese Trial to assess Optimal Systolic blood pressure in elderly hypertensive patients
Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension
Japan EPA Lipid Intervention Study
Japanese Rhythm management trial for atrial fibrillation
Kronos Early Estrogen Prevention Study
Korean Health and Genome Study
Lower Extremity Arterial Disease Event Reduction
Action for Health in Diabetes
Melatonin Adjunct in the acute myocardial Infarction treated with Angioplasty
Myocardial Infarction Secondary Prevention Study
Media Intima Thickness Evaluation of Candesartan
Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research
Prevention by low dose Aspirin of Cardiovascular disease in the Elderly
Paracetamol (Acetaminophen) In Stroke
Randomized Angiotensin receptor antagonist – ACE inhibitor Study
Resource utilization Among Congestive Heart failure
Risk factors, Evaluation of Coronary Calcium and Lifestyle
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycaemia in Diabetes
Reasons for Geographic And Racial Differences in Stroke
Renin-Aldosterone
Randomised Olmesartan And Diabetes Microalbuminuria Prevention
Stop Atherosclerosis in Native Diabetics Study
Shock Inhibition Evaluation with Azimilide
Telmisartan Effectiveness on Left ventricular Mass Reduction
Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure
Thrombolysis in Cardiac Arrest
Veterans Affairs Diabetes Trial
Valsartan Cardio-Renal Protection
Valsartan In Diastolic Dysfunction
Valsartan in elderly Isolated Systolic Hypertension
Women’s Antioxidant Cardiovascular Study
What's What

Back

Close window